BIOMARIN PHARMACEUTICAL INC Other Noncash Income
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Other Noncash Income of -$721.00 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncome · last filed 2015-08-05
- BIOMARIN PHARMACEUTICAL INC other noncash income for the quarter ending 2015-06-30 was -$1.16M.
- BIOMARIN PHARMACEUTICAL INC other noncash income for the quarter ending 2015-03-31 was $443.00K.
| Period end | Other Noncash Income 3 month | Other Noncash Income 6 month |
|---|---|---|
| 2015-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$721.00K 10-Q · filed 2015-08-05 |
| 2015-03-31 | $443.00K 10-Q · filed 2015-05-05 | |
| 2014-06-30 | -$1.88M 10-Q · filed 2015-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |